Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging, Cine | 10 | 2023 | 159 | 1.920 |
Why?
|
Heart | 6 | 2019 | 539 | 1.750 |
Why?
|
Magnetic Resonance Imaging | 19 | 2022 | 3352 | 1.580 |
Why?
|
Imaging, Three-Dimensional | 6 | 2018 | 579 | 1.320 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2018 | 663 | 1.230 |
Why?
|
Heart Ventricles | 10 | 2022 | 760 | 1.130 |
Why?
|
Coronary Artery Disease | 4 | 2022 | 350 | 0.910 |
Why?
|
Algorithms | 9 | 2019 | 1830 | 0.850 |
Why?
|
Myocardium | 3 | 2019 | 529 | 0.760 |
Why?
|
Magnetic Resonance Angiography | 2 | 2014 | 261 | 0.730 |
Why?
|
Image Enhancement | 6 | 2019 | 563 | 0.730 |
Why?
|
Breath Holding | 2 | 2017 | 22 | 0.720 |
Why?
|
Coronary Angiography | 3 | 2019 | 232 | 0.640 |
Why?
|
Ventricular Function, Left | 6 | 2022 | 592 | 0.630 |
Why?
|
Gadolinium | 5 | 2023 | 103 | 0.630 |
Why?
|
Subtraction Technique | 1 | 2016 | 133 | 0.540 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2018 | 1204 | 0.520 |
Why?
|
Defibrillators, Implantable | 3 | 2023 | 129 | 0.520 |
Why?
|
Reproducibility of Results | 14 | 2022 | 2705 | 0.520 |
Why?
|
Ventricular Dysfunction, Right | 3 | 2022 | 134 | 0.490 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2019 | 318 | 0.480 |
Why?
|
Ventricular Function, Right | 4 | 2022 | 142 | 0.420 |
Why?
|
Popliteal Artery | 1 | 2011 | 27 | 0.410 |
Why?
|
Stroke Volume | 6 | 2022 | 456 | 0.380 |
Why?
|
Contrast Media | 6 | 2023 | 1077 | 0.380 |
Why?
|
Tachycardia, Ventricular | 2 | 2023 | 115 | 0.360 |
Why?
|
Hydrogels | 2 | 2021 | 82 | 0.360 |
Why?
|
Coronary Vessels | 3 | 2015 | 177 | 0.330 |
Why?
|
Signal-To-Noise Ratio | 3 | 2018 | 96 | 0.310 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2019 | 47 | 0.300 |
Why?
|
Myocardial Infarction | 3 | 2017 | 375 | 0.300 |
Why?
|
Sensitivity and Specificity | 6 | 2016 | 1990 | 0.300 |
Why?
|
Swine | 3 | 2017 | 555 | 0.290 |
Why?
|
Extracellular Matrix | 3 | 2019 | 232 | 0.290 |
Why?
|
Tissue Engineering | 3 | 2021 | 181 | 0.280 |
Why?
|
Artifacts | 5 | 2021 | 244 | 0.280 |
Why?
|
Female | 23 | 2023 | 44507 | 0.260 |
Why?
|
Artificial Intelligence | 3 | 2022 | 298 | 0.250 |
Why?
|
Echocardiography | 2 | 2020 | 911 | 0.250 |
Why?
|
Humans | 30 | 2023 | 86601 | 0.250 |
Why?
|
Middle Aged | 16 | 2023 | 25017 | 0.240 |
Why?
|
Human Umbilical Vein Endothelial Cells | 2 | 2021 | 63 | 0.230 |
Why?
|
Male | 20 | 2023 | 40956 | 0.230 |
Why?
|
Phantoms, Imaging | 5 | 2018 | 429 | 0.230 |
Why?
|
Vasodilator Agents | 3 | 2022 | 152 | 0.220 |
Why?
|
Predictive Value of Tests | 6 | 2023 | 1673 | 0.210 |
Why?
|
Cardiac Surgical Procedures | 2 | 2018 | 462 | 0.210 |
Why?
|
Drug Carriers | 2 | 2015 | 81 | 0.210 |
Why?
|
Prospective Studies | 5 | 2019 | 4210 | 0.200 |
Why?
|
Myocardial Contraction | 2 | 2019 | 244 | 0.190 |
Why?
|
Immobilized Proteins | 1 | 2019 | 14 | 0.180 |
Why?
|
Adult | 13 | 2020 | 25640 | 0.180 |
Why?
|
Cardiomyopathies | 1 | 2022 | 240 | 0.180 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 274 | 0.170 |
Why?
|
Proteolysis | 1 | 2019 | 100 | 0.170 |
Why?
|
Isotopes | 1 | 2019 | 26 | 0.170 |
Why?
|
Coronary Circulation | 2 | 2022 | 130 | 0.170 |
Why?
|
Oligopeptides | 1 | 2019 | 179 | 0.170 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2018 | 12 | 0.170 |
Why?
|
Cicatrix | 1 | 2019 | 63 | 0.170 |
Why?
|
Perfusion Imaging | 1 | 2019 | 50 | 0.160 |
Why?
|
Polyethylene Glycols | 1 | 2021 | 363 | 0.160 |
Why?
|
Tetralogy of Fallot | 1 | 2018 | 44 | 0.160 |
Why?
|
Myocardial Ischemia | 1 | 2019 | 162 | 0.160 |
Why?
|
Regeneration | 2 | 2016 | 143 | 0.160 |
Why?
|
Healthy Volunteers | 2 | 2015 | 143 | 0.150 |
Why?
|
Cerebrovascular Circulation | 1 | 2019 | 212 | 0.150 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2022 | 567 | 0.150 |
Why?
|
Rest | 1 | 2016 | 48 | 0.140 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2015 | 19 | 0.130 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2015 | 57 | 0.130 |
Why?
|
Respiration | 1 | 2017 | 262 | 0.130 |
Why?
|
Data Compression | 1 | 2014 | 5 | 0.130 |
Why?
|
Ventricular Remodeling | 1 | 2015 | 96 | 0.130 |
Why?
|
Feasibility Studies | 2 | 2019 | 751 | 0.120 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 827 | 0.120 |
Why?
|
Body Surface Potential Mapping | 1 | 2014 | 22 | 0.120 |
Why?
|
Diaphragm | 1 | 2014 | 50 | 0.120 |
Why?
|
Disease Models, Animal | 2 | 2019 | 2232 | 0.120 |
Why?
|
Exercise Test | 1 | 2014 | 164 | 0.120 |
Why?
|
Aged | 9 | 2023 | 18402 | 0.110 |
Why?
|
Intestine, Small | 1 | 2015 | 303 | 0.110 |
Why?
|
Radiography | 1 | 2015 | 813 | 0.110 |
Why?
|
Diastole | 2 | 2010 | 144 | 0.110 |
Why?
|
Automation | 2 | 2010 | 106 | 0.110 |
Why?
|
Observer Variation | 3 | 2019 | 602 | 0.100 |
Why?
|
Animals | 5 | 2019 | 26581 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2023 | 318 | 0.090 |
Why?
|
Software | 1 | 2014 | 654 | 0.090 |
Why?
|
Young Adult | 5 | 2020 | 5974 | 0.090 |
Why?
|
Heart Failure | 1 | 2018 | 1203 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 364 | 0.080 |
Why?
|
Liposomes | 1 | 2008 | 91 | 0.080 |
Why?
|
Echocardiography, Doppler | 1 | 2009 | 187 | 0.080 |
Why?
|
Models, Anatomic | 1 | 2008 | 91 | 0.080 |
Why?
|
ROC Curve | 1 | 2009 | 752 | 0.070 |
Why?
|
Heart Rate | 2 | 2019 | 492 | 0.070 |
Why?
|
Retrospective Studies | 4 | 2021 | 8475 | 0.070 |
Why?
|
Logistic Models | 1 | 2009 | 1185 | 0.070 |
Why?
|
Models, Animal | 2 | 2016 | 263 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 2600 | 0.060 |
Why?
|
Radiation Dosage | 2 | 2019 | 227 | 0.060 |
Why?
|
Time Factors | 3 | 2019 | 5209 | 0.060 |
Why?
|
Meals | 1 | 2022 | 22 | 0.050 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2022 | 57 | 0.050 |
Why?
|
Perfusion | 1 | 2022 | 203 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2023 | 187 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2008 | 735 | 0.050 |
Why?
|
Ischemia | 1 | 2022 | 243 | 0.050 |
Why?
|
Elastic Modulus | 1 | 2019 | 36 | 0.050 |
Why?
|
Machine Learning | 1 | 2021 | 232 | 0.040 |
Why?
|
Biocompatible Materials | 1 | 2021 | 193 | 0.040 |
Why?
|
Middle Cerebral Artery | 1 | 2019 | 21 | 0.040 |
Why?
|
Hypercapnia | 1 | 2019 | 43 | 0.040 |
Why?
|
Radiation Exposure | 1 | 2019 | 24 | 0.040 |
Why?
|
Exercise | 1 | 2022 | 315 | 0.040 |
Why?
|
Microspheres | 1 | 2019 | 101 | 0.040 |
Why?
|
Motion | 1 | 2019 | 85 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2019 | 35 | 0.040 |
Why?
|
Multimodal Imaging | 1 | 2019 | 110 | 0.040 |
Why?
|
Workflow | 1 | 2019 | 77 | 0.040 |
Why?
|
Systole | 1 | 2018 | 129 | 0.040 |
Why?
|
Blood Glucose | 1 | 2022 | 873 | 0.040 |
Why?
|
Dogs | 1 | 2019 | 685 | 0.040 |
Why?
|
Iron | 1 | 2018 | 164 | 0.040 |
Why?
|
Computed Tomography Angiography | 1 | 2019 | 131 | 0.040 |
Why?
|
Pattern Recognition, Automated | 1 | 2018 | 217 | 0.040 |
Why?
|
Regression Analysis | 1 | 2018 | 596 | 0.040 |
Why?
|
Insulin | 1 | 2022 | 1160 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2018 | 6501 | 0.040 |
Why?
|
Pilot Projects | 1 | 2019 | 839 | 0.040 |
Why?
|
Prostheses and Implants | 1 | 2016 | 121 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 2062 | 0.030 |
Why?
|
Purines | 1 | 2016 | 91 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 466 | 0.030 |
Why?
|
Sus scrofa | 1 | 2015 | 45 | 0.030 |
Why?
|
Silicon | 1 | 2015 | 18 | 0.030 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2015 | 39 | 0.030 |
Why?
|
Electrodes | 1 | 2015 | 78 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2015 | 116 | 0.030 |
Why?
|
Brain Mapping | 1 | 2018 | 548 | 0.030 |
Why?
|
Carbon | 1 | 2015 | 80 | 0.030 |
Why?
|
Pyrazoles | 1 | 2016 | 153 | 0.030 |
Why?
|
Supine Position | 1 | 2014 | 30 | 0.030 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2014 | 33 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2019 | 1804 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2014 | 90 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2014 | 153 | 0.030 |
Why?
|
Infection Control | 1 | 2015 | 115 | 0.030 |
Why?
|
Equipment Design | 1 | 2014 | 406 | 0.030 |
Why?
|
Adenosine | 1 | 2016 | 225 | 0.030 |
Why?
|
Reference Values | 1 | 2014 | 674 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2014 | 201 | 0.030 |
Why?
|
Electrocardiography | 1 | 2015 | 478 | 0.030 |
Why?
|
Chronic Disease | 1 | 2016 | 970 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2019 | 3636 | 0.030 |
Why?
|
Action Potentials | 1 | 2015 | 573 | 0.030 |
Why?
|
Complement C5 | 1 | 1991 | 14 | 0.030 |
Why?
|
Interleukin-8 | 1 | 1991 | 86 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 1991 | 71 | 0.020 |
Why?
|
Bronchi | 1 | 1991 | 229 | 0.020 |
Why?
|
Stroke | 1 | 2019 | 965 | 0.020 |
Why?
|
Particle Size | 1 | 2008 | 122 | 0.020 |
Why?
|
Brain | 1 | 2018 | 2216 | 0.020 |
Why?
|
Electricity | 1 | 2008 | 23 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2018 | 2207 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 1920 | 0.020 |
Why?
|
Adolescent | 1 | 2018 | 8979 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2010 | 1801 | 0.020 |
Why?
|
Lung Diseases, Obstructive | 1 | 1991 | 19 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1991 | 121 | 0.010 |
Why?
|
Pulmonary Fibrosis | 1 | 1991 | 123 | 0.010 |
Why?
|
Neutrophils | 1 | 1991 | 307 | 0.010 |
Why?
|